Michael Harlin, partner in the firm’s Intellectual Property group, was recently quoted in the IAM article "CAFC Decision Prevents Skinny Label Use, Warns Dissenting Judge," published on October 14.  In the article, Mike discusses the impact of the Federal Circuit's recent decision regarding induced off-label infringement by generic drug producer Teva, overturning a district court judgment.

Click here to read the article (subscription required).